C. Rubbi

发表

Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus

J. Milner, C. Rubbi, 2000, Oncogene.

p53: Guardian of a Genome's Guardian?

J. Milner, C. Rubbi, 2003, Cell cycle.

p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage

J. Milner, C. Rubbi, 2003, The EMBO journal.

Analysis of nucleotide excision repair by detection of single-stranded DNA transients.

J. Milner, C. Rubbi, 2001, Carcinogenesis.

A simple immunomagnetic bead-based technique for the detection of surface molecules capable of inducing T cell functional polarisation.

C. Rubbi, D. Rickwood, 1996, Journal of immunological methods.

An investigation into the use of protein cross-linking agents as cell fixatives for confocal microscopy.

C. Rubbi, D. Rickwood, J. Qiu, 1994, European journal of histochemistry : EJH.

Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity

J. Parsons, C. Rubbi, C. M. Nickson, 2017, Oncotarget.

Removal of LPS from a Brucella cytoplasmic fraction by affinity chromatography with an anti-LPS monoclonal antibody as immunosorbent.

C. Rubbi, F. Goldbaum, C. A. Fossati, 1994, Journal of medical microbiology.

Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses

C. Rubbi, F. Goldbaum, C. A. Fossati, 1992, Journal of clinical microbiology.

Evidence of surface antigen detachment during incubation of cells with immunomagnetic beads.

C. Rubbi, D. Rickwood, D. Patel, 1993, Journal of immunological methods.

Use of density perturbation to isolate immunologically distinct populations of cells.

C. Rubbi, D. Rickwood, D. Patel, 1993, Journal of immunological methods.

UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML

E. Bowman, K. Borden, J. Milner, 2003, Oncogene.

Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis.

Ming Jiang, J. Milner, C. Rubbi, 2004, Oligonucleotides.

Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses

J. Milner, C. Rubbi, Jo Milner, 2003, The EMBO journal.

P53: Gatekeeper, Caretaker or Both?

J. Milner, C. Rubbi, 2007 .

CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p

C. Rubbi, J. Slupsky, N. Kalakonda, 2015, PloS one.

Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

C. Rubbi, M. Boyd, N. Vlatković, 2013, Cellular and Molecular Life Sciences.

Separation of T and B lymphocytes from human peripheral blood mononuclear cells using density perturbation methods.

C. Rubbi, D. Rickwood, D. Patel, 1995, Clinica chimica acta; international journal of clinical chemistry.

The nucleolus directly regulates p53 export and degradation

C. Rubbi, M. Boyd, Mark T. Boyd, 2011, The Journal of cell biology.

p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress

J. Milner, T. Mee, C. Rubbi, 2001, Oncogene.

TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies

C. Rubbi, M. Wilkie, M. Boyd, 2020, Cancer letters.

Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.

J. Blaydes, C. Rubbi, A. Phillips, 2014, Cancer letters.

Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines

C. Rubbi, M. Wilkie, M. Boyd, 2021, Cancers.

The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage

J. Milner, S. Metcalfe, C. Rubbi, 2002, Oncogene.

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53

C. Rubbi, R. Eccles, D. Sibson, 2010, British Journal of Cancer.

Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

C. Rubbi, M. Boyd, N. Vlatković, 2014, Cellular and Molecular Life Sciences.

Tissue-specific therapeutic targeting of p53 in cancer: one size does not fit all.

C. Rubbi, M. Boyd, Kerryanne Crawford, 2011, Current pharmaceutical design.

Loss of MTBP expression is associated with reduced survival in a biomarker‐defined subset of patients with squamous cell carcinoma of the head and neck

T. Helliwell, C. Rubbi, M. Boyd, 2011, Cancer.

MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.

C. Rubbi, B. K. Park, R. Jenkins, 2011, Carcinogenesis.

The nucleolus directly regulates p53 export and degradation

C. Rubbi, M. Boyd, N. Vlatković, 2011, The Journal of cell biology.

MDM2 promotes cell motility and invasiveness through a RING‐finger independent mechanism

C. Rubbi, M. Boyd, H. Warburton, 2010, FEBS letters.